Earnings and other bad news kept these stocks out of today's rally.
News & Analysis: BioScrip
BIOS earnings call for the period ending December 31, 2018.
BioScrip's fourth-quarter results and merger with Option Care Enterprises aren't sitting well with shareholders.
BIOS earnings call for the period ending June 30, 2018.
BioScrip's third-quarter earnings report left a lot to be desired.
Shares of the home infusion care services company BioScrip are cratering today. Here's why.
Bioscrip diluted investors with a $62.5 million capital raise today.
The S&P 500 struggled to inch its way into positive territory today while BioScrip, Tuesday Morning, and Polypore all surged higher by double-digit percentages.
BioScrip shares dip despite the company delivering strong revenue growth in the fourth quarter. Should investors buy this dip or is there more than meets the eye to this earnings report?
A monstrous amount of economic data sends the S&P 500 to a new all-time high. Find out why BioScrip, Frontline, and Prosensa hurtled their way to the head of the pack.